• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞可渗透铁螯合剂作为潜在的癌症化疗药物。

Cell permeable iron chelators as potential cancer chemotherapeutic agents.

作者信息

Pahl Paula M B, Horwitz Lawrence D

机构信息

University of Colorado Health Sciences Center, Department of Medicine, Denver, CO 80262, USA.

出版信息

Cancer Invest. 2005;23(8):683-91. doi: 10.1080/07357900500359976.

DOI:10.1080/07357900500359976
PMID:16377587
Abstract

Iron is an essential micronutrient for the growth and function of all cells. It is, therefore, an attractive target for chemotherapeutic compounds. Numerous studies in vitro and in vivo provide evidence that iron chelators may be effective antitumor agents. Lipophilic iron chelators that are readily cell permeable and can bind intracellular iron stores may selectively kill cancer cells without damaging normal cells. In this review we discuss the role of iron in cellular processes and how these processes differ between normal and neoplastic cells. We also review the effects on normal and cancer cell growth of several lipophilic iron chelators.

摘要

铁是所有细胞生长和功能所必需的微量营养素。因此,它是化疗化合物的一个有吸引力的靶点。大量的体外和体内研究提供了证据,表明铁螯合剂可能是有效的抗肿瘤药物。亲脂性铁螯合剂易于透过细胞,能够结合细胞内的铁储存,可能会选择性地杀死癌细胞而不损害正常细胞。在这篇综述中,我们讨论了铁在细胞过程中的作用,以及这些过程在正常细胞和肿瘤细胞之间的差异。我们还综述了几种亲脂性铁螯合剂对正常细胞和癌细胞生长的影响。

相似文献

1
Cell permeable iron chelators as potential cancer chemotherapeutic agents.细胞可渗透铁螯合剂作为潜在的癌症化疗药物。
Cancer Invest. 2005;23(8):683-91. doi: 10.1080/07357900500359976.
2
Membrane transport and intracellular sequestration of novel thiosemicarbazone chelators for the treatment of cancer.新型硫代氨基甲肟螯合剂的跨膜转运和细胞内隔离及其在癌症治疗中的应用。
Mol Pharmacol. 2010 Oct;78(4):675-84. doi: 10.1124/mol.110.066126. Epub 2010 Jul 6.
3
Potential of iron chelators as effective antiproliferative agents.铁螯合剂作为有效的抗增殖剂的潜力。
Can J Physiol Pharmacol. 1997 Oct-Nov;75(10-11):1164-80.
4
Chelators at the cancer coalface: desferrioxamine to Triapine and beyond.癌症前沿的螯合剂:从去铁胺到曲拉滨及其他。
Clin Cancer Res. 2006 Dec 1;12(23):6876-83. doi: 10.1158/1078-0432.CCR-06-1954.
5
Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents: implications for prevention and therapy of viral diseases and cancer.作为新型抗病毒和抗癌药物靶点的必需病毒和细胞含锌和含铁金属蛋白:对病毒疾病和癌症预防及治疗的意义。
Anticancer Res. 2001 Mar-Apr;21(2A):931-57.
6
Iron chelators in cancer therapy.癌症治疗中的铁螯合剂。
Biometals. 2020 Oct;33(4-5):201-215. doi: 10.1007/s10534-020-00243-3. Epub 2020 Aug 5.
7
The evolution of iron chelators for the treatment of iron overload disease and cancer.用于治疗铁过载疾病和癌症的铁螯合剂的演变
Pharmacol Rev. 2005 Dec;57(4):547-83. doi: 10.1124/pr.57.4.2.
8
Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors.从旧到新的硫代氨基脲类化合物:不仅仅是核糖核苷酸还原酶抑制剂的铁螯合剂。
J Med Chem. 2009 Sep 10;52(17):5271-94. doi: 10.1021/jm900552r.
9
Synthesis and antiproliferating activity of iron chelators of hydroxyamino-1,3,5-triazine family.羟基氨基-1,3,5-三嗪类铁螯合剂的合成及抗增殖活性。
Bioorg Med Chem Lett. 2010 Jan 15;20(2):458-60. doi: 10.1016/j.bmcl.2009.11.130. Epub 2009 Dec 1.
10
Design of iron chelators with therapeutic application.具有治疗应用的铁螯合剂的设计。
Dalton Trans. 2012 Jun 7;41(21):6371-89. doi: 10.1039/c2dt12159j. Epub 2012 Mar 6.

引用本文的文献

1
Initial testing of TPO-receptor agonist eltrombopag in osteosarcoma patient-derived xenograft models by the pediatric preclinical testing consortium.儿科临床前试验联盟在骨肉瘤患者来源异种移植模型中对 TPO-受体激动剂艾曲泊帕的初步测试。
Pediatr Hematol Oncol. 2021 Feb;38(1):8-13. doi: 10.1080/08880018.2020.1802539. Epub 2020 Aug 17.
2
Analysis of the Interaction of Dp44mT with Human Serum Albumin and Calf Thymus DNA Using Molecular Docking and Spectroscopic Techniques.利用分子对接和光谱技术分析Dp44mT与人血清白蛋白及小牛胸腺DNA的相互作用
Int J Mol Sci. 2016 Jun 30;17(7):1042. doi: 10.3390/ijms17071042.
3
Interaction of Di-2-pyridylketone 2-pyridine Carboxylic Acid Hydrazone and Its Copper Complex with BSA: Effect on Antitumor Activity as Revealed by Spectroscopic Studies.
2-吡啶基酮-2-吡啶羧酸腙及其铜配合物与牛血清白蛋白的相互作用:光谱研究揭示其对抗肿瘤活性的影响
Molecules. 2016 Apr 28;21(5):563. doi: 10.3390/molecules21050563.
4
Restoring the secretory function of irradiation-damaged salivary gland by administrating deferoxamine in mice.通过给小鼠施用去铁胺恢复受辐射损伤唾液腺的分泌功能。
PLoS One. 2014 Nov 26;9(11):e113721. doi: 10.1371/journal.pone.0113721. eCollection 2014.
5
Distinct mechanisms of cell-kill by triapine and its terminally dimethylated derivative Dp44mT due to a loss or gain of activity of their copper(II) complexes.曲安西平和其末端二甲基化衍生物Dp44mT通过其铜(II)配合物活性的丧失或获得导致细胞杀伤的不同机制。
Biochem Pharmacol. 2014 Oct 1;91(3):312-22. doi: 10.1016/j.bcp.2014.08.006. Epub 2014 Aug 15.
6
The cytotoxicity of benzaldehyde nitrogen mustard-2-pyridine carboxylic acid hydrazone being involved in topoisomerase IIα inhibition.苯甲醛氮芥-2-吡啶羧酸腙的细胞毒性与拓扑异构酶IIα抑制作用有关。
Biomed Res Int. 2014;2014:527042. doi: 10.1155/2014/527042. Epub 2014 Jun 5.
7
The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses.致病性分枝杆菌的外螯菌素:独特、高效、脂溶性和水溶性兼具的六齿铁螯合剂,具有多种潜在治疗用途。
Antioxid Redox Signal. 2014 Dec 1;21(16):2246-61. doi: 10.1089/ars.2013.5789. Epub 2014 Jun 20.
8
The neglected significance of "antioxidative stress".“抗氧化应激”被忽视的意义。
Oxid Med Cell Longev. 2012;2012:480895. doi: 10.1155/2012/480895. Epub 2012 May 8.
9
Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation.依鲁替尼通过减少细胞内铁和诱导分化来抑制白血病细胞的增殖。
Blood. 2012 Jul 12;120(2):386-94. doi: 10.1182/blood-2011-12-399667. Epub 2012 May 24.
10
Curcumin inhibits growth of Saccharomyces cerevisiae through iron chelation.姜黄素通过铁螯合作用抑制酿酒酵母的生长。
Eukaryot Cell. 2011 Nov;10(11):1574-81. doi: 10.1128/EC.05163-11. Epub 2011 Sep 9.